Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Salman Armed Forces Hospital.
Dr. Adher D. Al-Sayed is a medical oncologist whose professional work has focused on breast cancer and the treatment of complex breast malignancies. He has been associated with the Department of Medical Oncology at King Faisal Specialist Hospital and Research Centre (KFSH&RC), Riyadh, Saudi Arabia, where his clinical and research contributions have addressed breast cancer treatment, tumour response, and emerging therapeutic approaches.
Dr. Al-Sayed's published work demonstrates particular involvement in the management of uncommon and aggressive breast cancer subtypes, including metaplastic breast carcinoma and triple-negative breast cancer. These conditions can present significant treatment challenges because of their biological characteristics and, in some cases, limited response to conventional systemic therapies. His research has contributed to the medical literature examining clinical presentation, treatment outcomes, prognostic factors, and responses to newer treatment combinations.
One of his notable publications is the 2006 study, Metaplastic Carcinoma of the Breast: Clinical Presentation, Treatment Results and Prognostic Factors, published in Acta Oncologica. The research examined the clinical characteristics and treatment outcomes of patients with metaplastic breast carcinoma, contributing to the understanding of this uncommon breast cancer subtype.
Dr. Al-Sayed also contributed to research investigating the treatment of metastatic metaplastic breast cancer. In 2019, he co-authored a case report documenting a complete response in a patient with chemotherapy-refractory metastatic metaplastic breast cancer following a combination of paclitaxel and immunotherapy. This work highlighted the potential role of immunotherapy-based combinations in selected patients with difficult-to-treat breast cancer.
His research activities have also included investigations into breast cancer biology and the tumour microenvironment. He contributed to studies examining the relationship between breast adipocytes, inflammation, and tumour development, including research on interleukin-8 and the biological behaviour of breast cancer-associated adipocytes. These studies reflect the importance of understanding interactions between cancer cells and surrounding tissue when developing new treatment strategies.
Dr. Al-Sayed has additionally participated in research examining systemic treatment approaches for metastatic triple-negative breast cancer. His published work includes investigations into chemo-immunotherapy combinations and the association between eosinophil levels and treatment response. He has also contributed to clinical research involving breast cancer screening and the broader management of oncology patients.
His scientific contributions extend to professional discussions on contemporary breast cancer management. At the 2026 Annual Conference of the Saudi Society of Breast and Endocrine Surgery, Dr. Al-Sayed was listed as a speaker on two subjects: the management of pregnancy-associated breast cancer and developments in radiation therapy, including hypofractionation and partial-breast irradiation. These subjects address important aspects of individualized breast cancer treatment, particularly for patients whose clinical circumstances require careful coordination between oncology, surgery, and radiation oncology.
Through his clinical oncology work and research contributions, Dr. Al-Sayed has been involved in advancing knowledge of breast cancer treatment, particularly in aggressive and uncommon disease subtypes. His published research reflects an interest in improving therapeutic options and understanding how emerging systemic treatments may benefit patients with challenging breast malignancies.

Saudi Society of Breast & Endocrine Surgery (SSBES)
Saudi Society of Breast & Endocrine Surgery (SSBES)